Lauren Danielle Pomerantz

Years Active: 2021-2021
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Alison J Moskowitz, Paola Ghione, Eric D Jacobsen, Jia Ruan, Jonathan H Schatz, Sarah J Noor, Patricia L Myskowski, Santosha A Vardhana, Nivetha Ganesan, Helen Hancock, Theresa Davey, Leslie Perez, Sunyoung Ryu, Alayna Marie Santarosa, Jack Dowd, Obadi Obadi, Lauren Danielle Pomerantz, Nancy Yi, Samia Sohail, Natasha Galasso, Rachel Neuman, Brielle Liotta, William Blouin, Jeeyeon Baik, Mark Blaine Geyer, Ariela Noy, David J Straus, Priyadarshini Kumar, Ahmet Dogan, Travis J Hollmann, Esther Drill, Jürgen Rademaker, Heiko Schöder, Giorgio Ga Inghirami, David M Weinstock, Steven M Horwitz
Phase II biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas. Blood (2021)

Lauren Danielle Pomerantz.css-eqlu8i{font-size:small;padding-left:4px;}